General Information of Drug (ID: DM31E6J)

Drug Name
2-Methoxy-N-(3-methyl-2-phenyl-butyl)-benzamide
Synonyms CHEMBL16450; 2-Methoxy-N-(3-methyl-2-phenyl-butyl)-benzamide
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 297.4
Logarithm of the Partition Coefficient (xlogp) 4
Rotatable Bond Count (rotbonds) 6
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C19H23NO2
IUPAC Name
2-methoxy-N-(3-methyl-2-phenylbutyl)benzamide
Canonical SMILES
CC(C)C(CNC(=O)C1=CC=CC=C1OC)C2=CC=CC=C2
InChI
InChI=1S/C19H23NO2/c1-14(2)17(15-9-5-4-6-10-15)13-20-19(21)16-11-7-8-12-18(16)22-3/h4-12,14,17H,13H2,1-3H3,(H,20,21)
InChIKey
XVFLGHVOMBWJAC-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44270882
TTD ID
D04UVC

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Voltage-gated potassium channel Kv1.3 (KCNA3) TTY3UE6 KCNA3_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Benzamide derivatives as blockers of Kv1.3 ion channel. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1161-4.